Neurology Central

First disease-modifying therapy approved for pediatric multiple sclerosis: industry news round-up

This week’s industry news round-up reveals the latest updates including neuroblastoma, DUB inhibitors for neurodegenerative disorders and the first disease-modifying therapy for pediatric multiple sclerosis. Find out more about our selection of the highlights below.
Our pick of the highlights include:

Leave A Comment